Verve Therapeutics Inc (VERV)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 994.04M
P/E Ratio
0.00
Revenue (TTM)
$ 59.61M
Volume
0
52W High
$ 11.40
52W Low
$ 2.86
Dividend Yield
0.00%
Beta
2.24
Technicals
50-Day MA
8.4928
200-Day MA
6.549
52 Week High
11.405
52 Week Low
2.8647
About VERV
Verve Therapeutics, Inc., a clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.
Employees
274
Headquarters
Boston, MA
CEO
Dr. Burt A. Adelman M.D.